(HealthDay)—For men with low-risk prostate cancer, vascular targeted photodynamic therapy achieves an 82 percent rate of absent clinically significant cancer in treated lobes, according to a study published in the August ...
1
0
When it comes to arresting cancer's joyride through the body, one Western researcher's work looks to be the 'traffic cop' on the bloodstream highway.
1
0
(HealthDay)—For men who have had or might undergo a vasectomy, there is good news: A major study finds scant evidence that the procedure raises their risk of prostate cancer.
3
0
Prostate cancer is the most common cancer in men in Europe and the second most frequently diagnosed cancer in men worldwide.
8
0
A major 20-year study provides further evidence that prostate cancer surgery offers negligible benefits to many men with early-stage disease. In such men, who account for most cases of newly diagnosed prostate cancer, surgery ...
111
0
(HealthDay)—For patients newly diagnosed with prostate cancer who attend a multidisciplinary clinic, decisional regret does not differ significantly between treatment groups, according to a study published online July 5 ...
1
0
A form of genetic variation, called differential RNA splicing, may have a role in tumor aggressiveness and drug resistance in African American men with prostate cancer. Researchers at the George Washington University (GW) ...
25
0
Scientists have had limited success at identifying specific inherited genes associated with prostate cancer, despite the fact that it is one of the most common non-skin cancers among men. Researchers at University of Utah ...
40
0
Cleveland Clinic researchers have shown for the first time how a class of advanced prostate cancer drugs are processed in the body and how their anti-tumor activity might change depending on how they are metabolized. Their ...
2
0
(HealthDay)—Novel biomarkers have been identified that may have utility for predicting prostate cancer in non-African-American men, according to a study published in the July issue of The Journal of Urology.
0
0
Subscribe to rss feed
